Holen Sie sich die Stockscreener-App
22.25
2.05%
-0.465
Handel nachbörslich:
22.89
0.635
+2.85%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving AverageTime to Sell? - marketbeat.com
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance
TNDM|Tandem Diabetes Care Inc|Price:22.617|Chg%:-0.513 - TradingKey
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript - AOL.com
(TNDM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings - DirectorsTalk Interviews
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today - Yahoo Finance
TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum - finance.yahoo.com
Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results - Yahoo Finance
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - stocktwits.com
Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight - Sahm
TNDM Maintained by Citigroup -- Price Target Raised to $21.00 - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Deutsche Bank Adjusts Tandem Diabetes Care PT to $18 From $15.50, Maintains Hold Rating - Moomoo
Oppenheimer reiterates Tandem Diabetes stock rating on pharmacy gains By Investing.com - Investing.com South Africa
TNDM Maintained by RBC Capital -- Price Target Lowered to $26 - GuruFocus
Tandem Diabetes Care Is Maintained at Outperform by RBC Capital - Moomoo
Tandem Diabetes Care, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:TNDM) 2026-08-07 - Seeking Alpha
Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says - marketscreener.com
Tandem Diabetes Care Q2 Earnings Call Highlights - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap DownWhat's Next? - MarketBeat
Tandem Diabetes Care Inc (TNDM) Stock News Today - TradingKey
Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside - TradingView
RBC Adjusts PT on Tandem Diabetes Care to $26 From $30, Maintains Outperform Rating - marketscreener.com
Tandem Diabetes Care, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results - BioSpace
Tandem Diabetes Care earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tandem Diabetes Care posts Q2 2026 profit beat - Investing.com Nigeria
TNDM Looks 37.4% Undervalued on GF Value™ Despite Unprofitable S - GuruFocus
TNDM Looks 37.4% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump - Morningstar
Is Tandem Diabetes Care Inc (TNDM) a Value Opportunity After Q2 Earnings Miss? GF Score: 66/100 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Tandem Diabetes Q2 2026 slides: PayGo model drives margin expansion - Investing.com
Tandem Diabetes Q2 2026 slides: margins surge amid PayGo shift - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations - Barchart.com
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Tandem Diabetes Care, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Earnings Flash (TNDM) Tandem Diabetes Care, Inc. Reports Q2 Revenue $254.6M, vs. FactSet Est of $255.0M - marketscreener.com
TANDEM DIABETES CARE INC 2026: Revenue $254.56M, EPS ($0.31) — 10-Q Summary - TradingView
Q2 2026 Tandem Diabetes Care Inc Earnings Call Transcript - GuruFocus
Tandem Diabetes Care Q2 revenue slightly misses estimates - TradingView
Tandem Diabetes Care reports Q2 2026 revenue $254.6M, gross margin 57% - TradingView
Tandem Diabetes Care (NASDAQ: TNDM) lifts Q2 sales to $254.6M, trims loss - Stock Titan
BRIEF-Tandem Diabetes Care Q2 Net Income USD -21.2 Million - TradingView
Tandem Diabetes Care, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Voya Financial (TNDM holder) discloses 149,088 Tandem Diabetes Care shares in 13G/A - Stock Titan
Tandem Diabetes earnings on deck as pharmacy shift tests execution - Investing.com
Tandem Diabetes Earnings: What To Look For From TNDM - Barchart.com
Arrowstreet Capital Limited Partnership Raises Stake in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring a Promising 41.84% Upside Potential - DirectorsTalk Interviews
Tandem Poised to Launch Tubeless Mobi Pump - Morningstar
Tandem Diabetes Care Target of Unusually High Options Trading (NASDAQ:TNDM) - MarketBeat
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):